For: | Bajpai J, Pradhan A, Verma AK, Kant S. Use of hydroxychloroquine and azithromycin combination to treat the COVID-19 infection. World J Exp Med 2022; 12(3): 44-52 [PMID: 35765514 DOI: 10.5493/wjem.v12.i3.44] |
---|---|
URL: | https://www.wjgnet.com/2220-315x/full/v12/i3/44.htm |
Number | Citing Articles |
1 |
Raktim Swarnakar, Sankha Subhra Roy, Shiv Lal Yadav. Can hydroxychloroquine be used for COVID-19-induced arthritis? A debatable hypothesis. World Journal of Experimental Medicine 2022; 12(6): 108-110 doi: 10.5493/wjem.v12.i6.108
|
2 |
Tsvetelina Velikova, Hristo Valkov, Anita Aleksandrova, Monika Peshevska-Sekulovska, Metodija Sekulovski, Russka Shumnalieva. Harnessing immunity: Immunomodulatory therapies in COVID-19. World Journal of Virology 2024; 13(2): 92521 doi: 10.5501/wjv.v13.i2.92521
|
3 |
Paloma Seidel, Eva Spukti, Kerstin Steinbrink, Dieter Metze, Markus Böhm. Hydroxychloroquin – nicht immer ein harmloses Medikament für den Off-label-Gebrauch in der Dermatologie. Die Dermatologie 2024; 75(5): 412 doi: 10.1007/s00105-024-05294-y
|
4 |
Wassan Nori, Nabeeha Najatee Akram, Raid M Al-Ani. Update on hydroxychloroquine use in pregnancy. World Journal of Experimental Medicine 2023; 13(4): 99-101 doi: 10.5493/wjem.v13.i4.99
Abstract(513) |
Core Tip(512) |
Full Article(HTML)(1737)
|
Full Article with Cover (PDF)-545K(78)
|
Full Article (Word)-103K(34)
|
Audio-1788K(1)
|
Peer-Review Report-230K(44)
|
Answering Reviewers-85K(46)
|
Full Article (PDF)-351K(121)
|
Full Article (XML)-43K(51)
|
Times Cited (0)
|
Total Visits (4467)
|
Open
|
5 |
Neelam Kumari, Sarika Shukla, Deevena Jemima, Anjali Singh, Surya Kant. COVID-19 lockdown – Health and nutritional status of the general public in Lucknow. IP Indian Journal of Immunology and Respiratory Medicine 2022; 7(3): 104 doi: 10.18231/j.ijirm.2022.025
|
6 |
Elizabeth A.M. Frost. Long COVID—Will It Never End?. Topics in Pain Management 2022; 38(4): 1 doi: 10.1097/01.TPM.0000902752.53691.86
|
7 |
Marco Zeppieri. Ophthalmologic implications to consider when using hydroxychloroquine to treat COVID-19 and induced arthritis. World Journal of Experimental Medicine 2023; 13(4): 95-98 doi: 10.5493/wjem.v13.i4.95
Abstract(500) |
Core Tip(499) |
Full Article(HTML)(1292)
|
Full Article with Cover (PDF)-553K(69)
|
Full Article (Word)-103K(37)
|
Audio-345K(3)
|
Peer-Review Report-218K(41)
|
Answering Reviewers-111K(45)
|
Full Article (PDF)-359K(80)
|
Full Article (XML)-43K(41)
|
Times Cited (0)
|
Total Visits (3990)
|
Open
|